Malaria control in Africa: progress but still much to do
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
The Lancet
Abstract
During the past two decades, the international
community has invested heavily in malaria
control, especially in sub-Saharan Africa, with
support increasing from around US$100 million in
2000 to nearly $2 billion in 2013.1 How eff ective
has this investment been? Measurement of the
eff ect of enhanced eff orts to control malaria has
proved challenging. The main approaches used—
measurement of changes in deaths from malaria or
clinical episodes of the infection—each have major
methodological challenges.2 Estimates of the number
of deaths due to malaria rely to a large extent on
verbal autopsy, an imprecise method. Many infections
can cause illness resembling malaria; thus, estimates
of numbers of cases of malaria can be unreliable
unless supported by laboratory diagnoses. Strenuous
eff orts are being made to improve these approaches;
for example, ensuring that all reported clinical cases
have been confi rmed by a diagnostic test. However,
continuing imprecision is shown by the major
diff erences in the number of deaths attributed to
malaria in 2010 by WHO and the Institute of Health
Metrics: 655 000 and 1 238 000, respectively.3,4
An alternative is measurement of changes in the
prevalence of malaria infection detected by microscopy
or by a rapid diagnostic test. This approach could be
more precise because these methods are more specifi c
than verbal autopsy or clinical diagnosis of malaria.
This approach was adopted by Abdisalan Noor and
colleagues5 in an important new study in The Lancet.
The association between prevalence of malaria
infection and incidence of clinical malaria or malaria
mortality is not linear,6 so a reduction in parasite
prevalence cannot be assumed to be associated with
a reduction in the number of deaths from malaria or
cases of severe malaria. However, measurement of
changes in parasite prevalence can provide a valuable
way of assessing changes in the incidence of malaria
infection over time.
Noor and colleagues collected data from
26 746 malaria parasite prevalence surveys co vering
3 575 418 person-observations done across Africa
since 1980—a remarkable achievement. These data,
together with spatially matched covariates, were used
in a Bayesian hierarchical space–time model to derive
estimates of the proportion of the population aged
2–10 years with diff erent levels of malaria parasitaemia
(PfPR2–10) across Africa in 2000 and 2010.